Target- |
MechanismInflammation mediators stimulants |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date24 Dec 1997 |
100 Clinical Results associated with SPC Co., Ltd. (South Korea)
0 Patents (Medical) associated with SPC Co., Ltd. (South Korea)
100 Deals associated with SPC Co., Ltd. (South Korea)
100 Translational Medicine associated with SPC Co., Ltd. (South Korea)